Acton, MA, United States of America

Xiaoxia Chen

This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Sunovion Pharmaceuticals Inc., Sumitomo Pharma America, Inc.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoxia Chen. Retrieved from https://idiyas.com/inventor/xiaoxia-chen-vxbsm78i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with a detailed article about the inventor Xiaoxia Chen based on the given data.

Title: Unraveling the Innovations of Xiaoxia Chen: A Pioneer in Pharmaceutical Salts and Crystal Forms

Introduction:

Xiaoxia Chen, a distinguished inventor based in Acton, MA (US), has made significant contributions to the field of pharmaceuticals through his pioneering work in salts, crystal forms, and production methods. With a remarkable portfolio of 2 patents to his name, Xiaoxia Chen stands out as a visionary in the realm of drug development.

Latest Patents:

Chen's latest patents revolve around the creation of salts, crystal forms, and production methods of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine. These innovations encompass a range of crystal forms, compositions, medicaments, and pharmaceutically acceptable formulations, along with methods for their production. Moreover, Chen has delved into the development of compounds with specific particle size distributions, further showcasing his expertise in optimizing drug properties.

Career Highlights:

Currently affiliated with Sunovion Pharmaceuticals Inc., Xiaoxia Chen has been instrumental in driving forward advancements in pharmaceutical research and development. His strategic approach to drug design and formulation has led to groundbreaking discoveries that have the potential to revolutionize the pharmaceutical industry.

Collaborations:

In his professional journey, Chen has collaborated closely with notable peers such as Andrea Bauer and Shahla Jamzad. These collaborations have fostered a dynamic environment for innovation, where ideas are exchanged, and new paradigms are established in pharmaceutical science.

Conclusion:

In conclusion, Xiaoxia Chen epitomizes the essence of innovation in the pharmaceutical sector. His relentless pursuit of excellence and unwavering dedication to advancing drug technologies underscore his status as a trailblazer in the field. With a keen eye for detail and a passion for groundbreaking research, Chen continues to inspire and drive positive change in the realm of pharmaceutical salts and crystal forms.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…